Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Single-Blinded Phase II Trial to Assess the Efficacy, Safety and Acceptability of Oxantel Pamoate in Comparison to Mebendazole for Trichuris Trichiura Infections in Children Aged 2-12 Years

NCT06720259 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.

NCT NCT06720259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06720259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Single-Blinded Phase II Trial to Assess the Efficacy, Safety and Acceptability of Oxantel Pamoate in Comparison to Mebendazole for Trichuris Trichiura Infections in Children Aged 2-12 Years
Lead sponsor
Jennifer Keiser
Phase
Phase 2
Overall status
Completed
Start date
April 16, 2025
Completion date
May 28, 2025
Enrollment
163 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascaris lumbricoides infection, hookworm infection, trichuris trichiura; infection